A Global Leader in Innovative Radiopharmaceuticals for Diagnostics and Therapy
At Isotopia, we’re driven by a passion for pioneering excellence in radiopharmaceuticals to revolutionize patient care and advance the future of healthcare.
Since 2007, our unwavering focus has been on developing, manufacturing, and delivering cutting-edge diagnostic and therapeutic solutions in nuclear medicine that improve patient outcomes and quality of life.
Our Vision
To be the global leader in transforming nuclear medicine
through pioneering research, advanced manufacturing, and compassionate patient care.
Our Focus
Theranostics: As a major global supplier of GMP-grade
Lutetium-177, Isotopia is at the forefront of developing and commercializing innovative theragnostic solutions that combine diagnosis and therapy for precision medicine.
Diagnostics: Our diagnostic radiopharmaceuticals
offer advanced imaging capabilities, thus
enabling early detection and accurate diagnosis of various diseases, including cancer.
Radiopharmacy: Our state-of-the-art radiopharmacy
facilities produce a wide range of high-quality radiotracers, ensuring timely and reliable access for our customers.
CMO Services: We provide comprehensive contract manufacturing organization (CMO) services, supporting the development and commercialization of innovative radiop.
Our Global Operations
Israel:
Headquarters & Lu-177 Production Facility:
At our headquarters we are dedicated to the production of Lutetium-177 (Lu-177).
This site ensures consistent quality and supply for our ever-growing global customer base.
Offers a wide range of comprehensive services.
We specialize in the preparation, production, and quality control of ready-to-use PET and SPECT radiotracers, which enhance diagnostic accuracy and imaging quality.
Our aseptic plant in Israel specializes in the production of cold kits and offers comprehensive Contract Manufacturing Organization (CMO) services, including the
manufacture of sterile, lyophilized, and aseptic products for clinical trials and commercial applications.
Austria:
GMP-compliant Lu-177 Production:
Our Austrian facility adheres to Good Manufacturing Practice (GMP) standards, ensuring high-quality production of Lu-177 for therapeutic use, particularly in cancer treatment.
United States:
Lu-177 Isotopia Production:
Supporting North American operations, this site is focused on producing FDA-compliant Lu-177 Isotopia, meeting the needs of our customers across the entire region.
Looking Forward – Our Commitment to Patients
Isotopia is committed to expanding access to our life-saving products worldwide. We are actively pursuing marketing authorizations in multiple countries to bring hope to patients facing challenging medical conditions.
Isotopia is dedicated to working closely with healthcare providers, regulators, and the patient community worldwide to ensure that our products are accessible to all who can benefit from them.
